#cardiomastadon Given its superior efficacy and similar overall safety, #P2Y12inhibitor monotherapy might be preferred over #aspirin monotherapy for longterm secondary prevention in patients with #CAD

https://www.sciencedirect.com/science/article/abs/pii/S0735109723055936

#IDMastodon @jamanetworkopen #ICU In this RCT of 949 participants, use of a #P2Y12inhibitor did not result in a greater number of days alive & free of cardiovascular or respiratory organ support up to day 21 of the index hospitalization.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2805305?utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamanetworkopen&utm_content=wklyforyou&utm_term=052623